Five things you missed at the FDA refurb workshop
Current Location:
>
> This Story

starstarstarstarstar (3)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Siemens to acquire Corindus Vascular Robotics in $1.1 billion deal Royal currently has a 12.8 percent stake in Corindus

Health Catalyst IPO — The Signify View The industry analysts share their perspective on the announcement

RadNet acquires Nulogix, opens new AI division Will develop applications for image interpretation

Carestream completes sale of IT business to Philips in most countries Now part of Philips in 26 of 38 countries where it operates

Siemens rises above $4 billion in revenue in third quarter Revenue rose by 5.8 percent compared to last year

Siemens diagnostics president to step down, new board member appointed CEO Bernd Montag will assume responsibility of the business unit

Four tips to creating greater efficiencies in your imaging department Insights from the data obtained by Definitive Healthcare

Hospital M&A revenue rose to $11.3 billion in Q2 this year Atrium Health acquiring Wake Forest Baptist Health was most notable

Philips Q2 sales helped by Chinese healthcare spending Sales rose in the U.S. and Europe as well

UnitedHealth Group reported strong second quarter 2019 results, beating expectations Total revenues at $60.6 billion, up eight percent year over year

FDA headquarters in Silver Spring, MD

Five things you missed at the FDA refurb workshop

by Gus Iversen , Editor in Chief
The FDA’s docket workshop last week in Silver Spring, Maryland, brought together hundreds of stakeholders to discuss ambiguities in the definitions of certain terms relating to third-party involvement in the medical equipment industry.

Here are the opposing perspectives in under 100 words:

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



    OEMs want ISOs and HTMs to be regulated in some way — not because they feel all third-parties are bad, but because the limited data that exists includes evidence that some third-parties are not providing safe service.

    ISOs and HTMs point to the available statistics that illustrate their high level of success, and say the cost of regulations would put an unnecessary burden on the value they bring to the care system, while simultaneously strengthening OEM control and limiting competition.

That very general overview sums up a lot of the presentations given at the FDA headquarters last week, but a few presenters brought valuable new details into focus. Here are some highlights:

Who says HTMs and ISOs aren't already being regulated?

Multiple stakeholders, including representatives from AdvaMed and MITA, referred to Quality Service Regulations (QSRs) as a viable solution to the lack of scrutiny over third-party providers, and suggested these oversight protocols are scalable and could be customized depending on the company.

But others, like Barbara Maguire, vice president, Quality and Geisinger Clinical Engineering, ISS Solutions, points to CMS and the Joint Commission as entities that already provide adequate quality control on third-party service.

And as for selecting the ISOs that HTMs choose to work with, Maguire said that reviewing qualifications is already part of the job and adding regulations to it would be "redundant."

Jim Nestel, manager of service projects & installations with Hitachi, made the case on behalf of OEMs that not all ISOs have the stringent guidelines described by attendees. He pointed specifically at outpatient clinics, which he said frequently do not incorporate the best practices described by many of the ISOs and HTMs present at the workshop.

This theme of "present company excluded" ran throughout the event when referring to the dangers associated with certain third-parties.
  Pages: 1 - 2 - 3 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment